Journal article

Neurocognitive impairment associated with alcohol use disorders: Implications for treatment

ME Bates, SC Bowden, D Barry

Experimental and Clinical Psychopharmacology | AMER PSYCHOLOGICAL ASSOC | Published : 2002

Abstract

Between 50% and 80% of individuals with alcohol use disorders experience mild to severe neurocognitive impairment. There is a strong clinical rationale that neurocognitive impairment is an important source of individual difference affecting many aspects of addiction treatment, but empirical tests of the direct influence of impairment on treatment outcome have yielded weak and inconsistent results. The authors address the schism between applied- theoretical perspectives and research evidence by suggesting alternative conceptual models of the relationship between neurocognitive impairment and addiction treatment outcome. Methods to promote neurocognitive recovery and ways in which addiction tr..

View full abstract

University of Melbourne Researchers